<html>
<head>PUBMED IDs for PDLIM2</head>
<body bgcolor='#C5F0F2'><h1>PDLIM2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15659642/'>Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth.</a> January 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/19064727/'>Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB.</a> December 10  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19131544/'>PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation.</a> June 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19438970/'>NF-kappaB regulation: the nuclear response.</a> July 9  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19794962/'>Human T-cell leukemia virus type I-mediated repression of PDZ-LIM domain-containing protein 2 involves DNA methylation but independent of the viral oncoprotein tax.</a> January 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19794958/'>Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer.</a> January 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20185823/'>Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.</a> May 7  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20838382/'>Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis.</a> January 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21784097/'>Construction of a recombinant eukaryotic expression plasmid containing human PDLIM2 gene and its biological activity.</a> March 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23584482/'>PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D.</a> May 31  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24196835/'>PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.</a> August 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24863845/'>Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis.</a> March 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25681443/'>Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.</a> July 3  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25903579/'>Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.</a> April 6  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26374157/'>[PDLIM2 and Its Role in Oncogenesis--Tumor Suppressor or Oncoprote?].</a> November 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26499308/'>PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.</a> May 21  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27538486/'>Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.</a> August 20  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27538444/'>Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition.</a> August 20  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28126595/'>Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.</a> January 28  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28315683/'>Klotho ameliorates cyclosporine A-induced nephropathy via PDLIM2/NF-kB p65 signaling pathway.</a> March 20  2017<br></body></html>
